Morphic Holding, Inc. is a biopharmaceutical company focusing on developing integrin therapeutics for various diseases. Their lead product, MORF-057, is in Phase 2 trials for inflammatory bowel disease.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing